Embracing cancer complexity: Hallmarks of systemic disease
The last 50 years have witnessed extraordinary developments in understanding
mechanisms of carcinogenesis, synthesized as the hallmarks of cancer. Despite this logical …
mechanisms of carcinogenesis, synthesized as the hallmarks of cancer. Despite this logical …
Genetically-engineered mouse models of small cell lung cancer: the next generation
Small cell lung cancer (SCLC) remains the most fatal form of lung cancer, with patients in
dire need of new and effective therapeutic approaches. Modeling SCLC in an …
dire need of new and effective therapeutic approaches. Modeling SCLC in an …
Advances of osteosarcoma models for drug discovery and precision medicine
L Tan, Y Wang, X Hu, G Du, X Tang, L Min - Biomolecules, 2023 - mdpi.com
The management of osteosarcoma (OS) patients presents a significant clinical challenge.
Despite progress in conventional and targeted therapies, the survival rate of OS patients …
Despite progress in conventional and targeted therapies, the survival rate of OS patients …
[HTML][HTML] Analysis of organoid and immune cell co-cultures by machine learning-empowered image cytometry
P Stüve, B Nerb, S Harrer, M Wuttke, M Feuerer… - Frontiers in …, 2024 - frontiersin.org
Organoids are three-dimensional (3D) structures that can be derived from stem cells or adult
tissue progenitor cells and exhibit an extraordinary ability to autonomously organize and …
tissue progenitor cells and exhibit an extraordinary ability to autonomously organize and …
Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids
P Bustamante-Madrid, A Barbáchano… - Cell Death & …, 2024 - nature.com
Understanding the mechanisms involved in colonic epithelial differentiation is key to
unraveling the alterations causing inflammatory conditions and cancer. Organoid cultures …
unraveling the alterations causing inflammatory conditions and cancer. Organoid cultures …
[HTML][HTML] OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway
H Wei, W Li, L Zeng, N Ding, K Li… - Molecular …, 2024 - molecular-cancer.biomedcentral …
Intestinal metaplasia (IM) is classified into complete intestinal metaplasia (CIM) and
incomplete intestinal metaplasia (IIM). Patients diagnosed with IIM face an elevated …
incomplete intestinal metaplasia (IIM). Patients diagnosed with IIM face an elevated …
[HTML][HTML] Spatial Transcriptomics: A Powerful Tool in Disease Understanding and Drug Discovery
J Cao, C Li, Z Cui, S Deng, T Lei, W Liu, H Yang… - Theranostics, 2024 - ncbi.nlm.nih.gov
Recent advancements in modern science have provided robust tools for drug discovery. The
rapid development of transcriptome sequencing technologies has given rise to single-cell …
rapid development of transcriptome sequencing technologies has given rise to single-cell …
[HTML][HTML] The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo [d] imidazole derivatives as potential anticancer agents
SJ Park, I Song, GS Yeom, SB Nimse - Biomedicine & Pharmacotherapy, 2024 - Elsevier
In this study, a series of 2-Aryl-1H-benzo [d] imidazole derivatives were developed to target
intra-and extracellular microtubule networks. Compounds O-7 and O-10 showed impressive …
intra-and extracellular microtubule networks. Compounds O-7 and O-10 showed impressive …
微乳头型肺腺癌类器官的构建及其靶向药物的筛选.
姜忠敏, 张春艳, 刘敏, 郑洁, 李艳霞… - Tianjin Medical …, 2024 - search.ebscohost.com
目的建立微乳头型肺腺癌类器官的培养方法, 并开展靶向药物的筛选. 方法自确诊为微乳头型肺
腺癌患者手术组织样本中提取和培养原代肺癌类器官, 动态观察和记录肺癌类器官生长情况; …
腺癌患者手术组织样本中提取和培养原代肺癌类器官, 动态观察和记录肺癌类器官生长情况; …
Combining Scalable Organ Chip Platform with Deep Learning-Based Imaging Analysis for Cancer Therapeutic Screening
YC Yuan, B Xu, J McCormack, XH Huang, J Ma… - bioRxiv, 2024 - biorxiv.org
Functional precision oncology represents an emerging approach to genomic approaches by
testing treatment options directly on patient-derived models. Current assays, including the …
testing treatment options directly on patient-derived models. Current assays, including the …